Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
SKF-96365 treatment inhibits the calcium/calmodulin-dependent protein kinase IIγ (CaMKIIγ)/AKT signaling cascade
showing a greater affinity at depolarized (IC50=8 µM) than at resting (IC50=262 µM) potentials
Solubility: DMSO : ≥ 100 mg/mL (301
CYM-5520 also increases osteoblast number
100 and 220 nM for human D2
(S)-Lisofylline Catalog No.:M22422-C SKF-96365 treatment inhibits the calcium/calmodulin-dependentLisofylline (LSF) is a potent anti inflammatory agent. LSF is a chiral metabolite of pentoxifylline . Pentoxifylline is exclusively reduced to (S) LSF in the cytosol when metabolized by isolated human liver cells . In vitro: Lisofylline preserved cell insulin secretion and inhibited DNA damage of islets in the presence of IL 1 . Simultaneous application of LSF and cytokines to INS 1 cells restored insulin secretion, mitochondrial membrane potential,